Nuria Rodrı́guez-Salas

718 total citations
32 papers, 485 citations indexed

About

Nuria Rodrı́guez-Salas is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Nuria Rodrı́guez-Salas has authored 32 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Nuria Rodrı́guez-Salas's work include Colorectal Cancer Treatments and Studies (13 papers), Genetic factors in colorectal cancer (9 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). Nuria Rodrı́guez-Salas is often cited by papers focused on Colorectal Cancer Treatments and Studies (13 papers), Genetic factors in colorectal cancer (9 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). Nuria Rodrı́guez-Salas collaborates with scholars based in Spain, United States and France. Nuria Rodrı́guez-Salas's co-authors include Jaime Feliú, Joan Maurel, Xabier García‐Albéniz, Rodrigo Barderas, Jaime Feliú Batlle, Marta Mendiola, Victoria Heredia-Soto, Javier de Castro, D. Viñal and Manuel González-Barón and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

Nuria Rodrı́guez-Salas

30 papers receiving 478 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nuria Rodrı́guez-Salas Spain 13 307 140 114 99 81 32 485
Inge Ubink Netherlands 14 241 0.8× 145 1.0× 97 0.9× 86 0.9× 93 1.1× 19 459
Andrea Pretta Italy 12 272 0.9× 182 1.3× 139 1.2× 102 1.0× 59 0.7× 47 478
Aurélie Ferru France 11 250 0.8× 93 0.7× 86 0.8× 82 0.8× 84 1.0× 30 439
Hanguang Hu China 15 348 1.1× 113 0.8× 98 0.9× 114 1.2× 112 1.4× 47 533
Yen‐Jung Lu Taiwan 13 186 0.6× 167 1.2× 111 1.0× 87 0.9× 72 0.9× 21 416
Lee Gorden United States 8 205 0.7× 127 0.9× 154 1.4× 55 0.6× 42 0.5× 11 407
F. De Vita Italy 11 405 1.3× 198 1.4× 220 1.9× 196 2.0× 67 0.8× 37 691
Elisa Giommoni Italy 14 314 1.0× 158 1.1× 138 1.2× 180 1.8× 59 0.7× 45 527
A. Reinacher-Schick Germany 11 441 1.4× 175 1.3× 149 1.3× 146 1.5× 68 0.8× 46 636
Sheng Ye China 15 208 0.7× 283 2.0× 182 1.6× 131 1.3× 33 0.4× 36 585

Countries citing papers authored by Nuria Rodrı́guez-Salas

Since Specialization
Citations

This map shows the geographic impact of Nuria Rodrı́guez-Salas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nuria Rodrı́guez-Salas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nuria Rodrı́guez-Salas more than expected).

Fields of papers citing papers by Nuria Rodrı́guez-Salas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nuria Rodrı́guez-Salas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nuria Rodrı́guez-Salas. The network helps show where Nuria Rodrı́guez-Salas may publish in the future.

Co-authorship network of co-authors of Nuria Rodrı́guez-Salas

This figure shows the co-authorship network connecting the top 25 collaborators of Nuria Rodrı́guez-Salas. A scholar is included among the top collaborators of Nuria Rodrı́guez-Salas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nuria Rodrı́guez-Salas. Nuria Rodrı́guez-Salas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Barbáchano, Antonio, Nuria Rodrı́guez-Salas, I. Prieto, et al.. (2024). Vitamin D opposes multilineage cell differentiation induced by Notch inhibition and BMP4 pathway activation in human colon organoids. Cell Death and Disease. 15(4). 301–301. 7 indexed citations
3.
4.
Valladares‐Ayerbes, Manuel, María José Safont, Encarnación González‐Flores, et al.. (2024). Sequential RAS mutations evaluation in cell-free DNA of patients with tissue RAS wild-type metastatic colorectal cancer: the PERSEIDA (Cohort 2) study. Clinical & Translational Oncology. 26(10). 2640–2651. 2 indexed citations
5.
Prieto, I., Antonio Barbáchano, Nuria Rodrı́guez-Salas, et al.. (2023). Tailored chemotherapy for colorectal cancer peritoneal metastases based on a drug-screening platform in patient-derived organoids: a case report. Journal of Gastrointestinal Oncology. 14(1). 442–449. 5 indexed citations
6.
Escudero, Adela, et al.. (2022). Cancer predisposing syndrome: a retrospective cohort analysis in a pediatric and multidisciplinary genetic cancer counseling unit. International Journal of Clinical Oncology. 27(5). 992–1000. 3 indexed citations
7.
8.
García‐Alfonso, Pilar, Andrés J. Muñoz Martín, Paula Jiménez‐Fonseca, et al.. (2021). Early clinical experience with trifluridine/tipiracil for refractory metastatic colorectal cancer: The ROS study.. Journal of Clinical Oncology. 39(15_suppl). e15556–e15556. 1 indexed citations
9.
Heredia-Soto, Victoria, Nuria Rodrı́guez-Salas, & Jaime Feliú. (2021). Liquid Biopsy in Pancreatic Cancer: Are We Ready to Apply It in the Clinical Practice?. Cancers. 13(8). 1986–1986. 44 indexed citations
10.
Viñal, D., Javier Pérez Pedregosa, Oliver Higuera, et al.. (2020). Prognostic value of neutrophil-to-lymphocyte ratio in advanced cancer patients receiving immunotherapy. Clinical & Translational Oncology. 23(6). 1185–1192. 18 indexed citations
11.
12.
Beveridge, Robert Díaz, Ana Fernández Montés, Julia Alcaide, et al.. (2019). Update of metastatic colorectal cancer metastases resection after FOLFIRI-aflibercept in oxaliplatin-refractory patients. Annals of Oncology. 30. iv51–iv52. 1 indexed citations
13.
Fernández-Martos, Carlos, Carles Pericay, Ferrán Losa, et al.. (2019). Effect of Aflibercept Plus Modified FOLFOX6 Induction Chemotherapy Before Standard Chemoradiotherapy and Surgery in Patients With High-Risk Rectal Adenocarcinoma. JAMA Oncology. 5(11). 1566–1566. 36 indexed citations
14.
Viñal, D., et al.. (2019). Efficacy of capecitabine when used concomitantly with proton pump inhibitors in cancer patients: a systematic review. Clinical & Translational Oncology. 22(8). 1288–1294. 4 indexed citations
15.
Rodrı́guez-Salas, Nuria, Rodrigo Barderas, Marta Mendiola, et al.. (2016). Clinical relevance of colorectal cancer molecular subtypes. Critical Reviews in Oncology/Hematology. 109. 9–19. 105 indexed citations
16.
Sastre, Javier, Robert Díaz Beveridge, Jesús García‐Foncillas, et al.. (2015). Clinical guideline SEOM: hepatocellular carcinoma. Clinical & Translational Oncology. 17(12). 988–995. 23 indexed citations
17.
Custodio, Ana, Juan Moreno‐Rubio, Jorge Aparicio, et al.. (2014). Pharmacogenetic Predictors of Outcome in Patients with Stage II and III Colon Cancer Treated with Oxaliplatin and Fluoropyrimidine-Based Adjuvant Chemotherapy. Molecular Cancer Therapeutics. 13(9). 2226–2237. 10 indexed citations
18.
Feliú, Jaime, Beatriz Martínez, Javier de Castro, et al.. (2008). Descriptive analysis of clinical factors affecting terminally ill cancer patients. Supportive Care in Cancer. 17(3). 261–269. 14 indexed citations
19.
Espinosa, Enrique, et al.. (2000). Pregnancy in a breast cancer patient treated with a LHRH analogue at ablative doses. The Breast. 9(2). 110–112. 6 indexed citations
20.
Rodrı́guez-Salas, Nuria, et al.. (2000). Circulating Cancer Cells in Peripheral Blood. Acta Cytologica. 44(2). 237–241. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Inge Ubink Breakdown of academic impact, for papers by Andrea Pretta Breakdown of academic impact, for papers by Aurélie Ferru Breakdown of academic impact, for papers by Hanguang Hu Breakdown of academic impact, for papers by Yen‐Jung Lu Breakdown of academic impact, for papers by Lee Gorden Breakdown of academic impact, for papers by F. De Vita Breakdown of academic impact, for papers by Elisa Giommoni Breakdown of academic impact, for papers by A. Reinacher-Schick Breakdown of academic impact, for papers by Sheng Ye
Rankless by CCL
2026